Bioxcel Corporation
Branford, CT, US· latest recorded location
BIOXCEL CORPORATION is named on 2 US grants and 4 published applications in this corpus. Its most frequent classification is A61K (Medicines and medical preparations).
- Granted patents
- 2
- Published applications
- 4
- Inventors
- 5
- Granted in 2026 so far
- 0
- Most recent grant
- 7 Apr 2020
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2016 | 0 | 1 |
| 2017 | 0 | 2 |
| 2018 | 0 | 0 |
| 2019 | 0 | 1 |
| 2020 | 2 | 0 |
By publication year.
Technology areas
Share of 6 documents
- A61KMedicines and medical preparations3
- A61PTherapeutic uses of medicines3
- G06FComputing and data processing3
- G16HHealthcare informatics, i.e. information and communication technology [ict] specially adapted for the3
- G01NInvestigating or analysing materials by determining their chemical or physical properties2
- G16BBioinformatics, i.e. information and communication technology [ict] specially adapted for genetic or2
- G16CComputational chemistry2
- C07DHeterocyclic compounds1
Recent patents
- Use of ubiquitin-proteasome system inhibitors for treatment of tumors associated with neurofibromatosis type-27 Apr 2020US 10,610,563 B2
- Methods for reformulating and repositioning pharmaceutical data and devices thereof25 Feb 2020US 10,572,631 B2
- Use of src family kinase inhibitor in ribosomal disorder3 Oct 2019US 2019/0298720 A1
- Use of ubiquitin-proteasome system inhibitors for treatment of tumors associated with neurofibromatosis type-221 Dec 2017US 2017/0360872 A1
- Methods for reformulating and repositioning pharmaceutical data and devices thereof3 Aug 2017US 2017/0220767 A1
- Systems and methods to classify and rank health information3 Mar 2016US 2016/0063202 A1
Most cited
By later US patents
None of its patents has been cited by a later US patent yet.